 |
 |
 |
|
Micro-eliminating Hepatitis C in a network of 48 English Prisons
through an industry, prison healthcare and patient organisation partnership
|
|
|
EASL 2022 June 22-26 London
A JONES1; N ROYAL2; A LUDLOW-RHODES2; R CHEETHAM2; E MONGALE2; J HENDERSON2; K ABRAHAM2; H CUBBAGE2; S ALLEN2; L CHRISTENSEN3; K DORRINGTON1; A MILNER1; L MISSEN1; P TROKE1
1Medical Affairs, Gilead Sciences Ltd, London, UK 2Health in Justice, Practice Plus Group, Reading, UK 3The Hepatitis C Trust, London, UK





|
|
|
 |
 |
|
|